Tower Research Capital (TRC)’s NeuroOne Medical Technologies NMTC Stock Holding History
Bought
Maintained
Sold
Other funds holding NMTC
Tower Research Capital (TRC)'s NMTC Position: Q3 2026 in Review
Tower Research Capital (TRC) increased its NeuroOne Medical Technologies (NMTC) stake by 1,046% in Q3 2026, buying an estimated $2.2K and bringing the position to 1,283 shares worth $1.32K. The position accounts for ﹤0.01% of the portfolio, ranked #5312.
Tower Research Capital (TRC) first reported a position in NMTC in Q3 2021 and has held it in 17 quarters since. The position peaked at $20K in Q3 2021. 24 funds tracked by Wall St. Rank hold NMTC as of Q3 2026.
- Tower Research Capital (TRC) held 1,283 shares of NeuroOne Medical Technologies worth $1.32K as of Q3 2026.
- Tower Research Capital (TRC) bought 1,171 NeuroOne Medical Technologies shares in Q3 2026, an estimated $2.2K.
- NeuroOne Medical Technologies made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #5312 holding.
- Tower Research Capital (TRC) first reported a position in NeuroOne Medical Technologies in Q3 2021 and has held it in 17 quarters since.
- Tower Research Capital (TRC)'s NeuroOne Medical Technologies position peaked at $20K in Q3 2021.
- 24 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.